InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,535.66
(
0.48%
)
US TECH 100
19,714.00
(
0.37%
)
Dow Jones
39,185.73
(
-0.31%
)
Brent Oil
87.08
(
-0.29%
)
Bitcoin
55,609.66
(
-2.41%
)
Post# of 15810
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlwaysRed

Send PM Follow Ignore
Followers 63
Posts 3363
Boards Moderated 2
Alias Born 03/20/2019

AlwaysRed

Re: DegenerateGambler post# 14695

Friday, 02/26/2021 8:54:03 AM

Friday, February 26, 2021 8:54:03 AM

Post# of 15810
Pfizer Inc. and OPKO Health Inc. on Friday said the European Medicines Agency validated for review their marketing authorization application for somatrogon, a once-weekly human-growth hormone for pediatric patients with growth-hormone deficiency.

New York drug maker Pfizer said somatrogon, if approved, would help reduce the burden of daily growth-hormone injections, adding that it expects a decision from the European Commission in 2022.

Pfizer and OPKO, a Miami healthcare-services company, signed a worldwide agreement in 2014 to develop and commercialize somatrogon for growth-hormone deficiency. The U.S. Food and Drug Administration in January accepted for review the companies' application for somatrogon.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent OPK News
More OPK News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!